Financhill
Back

AbbVie Vs. Avidity Biosciences Industry Stock Comparison

Sell
40

ABBV
AbbVie

Last Price:
173.21
Seasonality Move:
3.38%
Sell
30

RNA
Avidity Biosciences

Last Price:
33.78
Seasonality Move:
53.96%
Sell
40
AbbVie (ABBV) is a Sell

Is AbbVie a Buy, Sell or Hold?

  • The current AbbVie [ABBV] share price is $174.37. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $35.58. The Score for RNA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABBV Stock Price Chart

What is AbbVie's stock price today?

  • The AbbVie share price today is $174.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing selling pressure, which indicates risk of future bearish movement.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $35.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.55 Sell
Relative Strength Index (14 RSI): 39.34 Sell
Chaikin Money Flow: -4801623 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (167.97 - 187.55) Sell
Bollinger Bands (100): (179.27 - 198.19) Sell

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.39 Sell
Relative Strength Index (14 RSI): 33.13 Sell
Chaikin Money Flow: -623231 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.44 - 47.22) Sell
Bollinger Bands (100): (41.03 - 46.99) Sell

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 177.34 Sell
20-day SMA: 174.86 Sell
50-day SMA: 185.9 Sell
200-day SMA: 178.97 Sell
8-day EMA: 176.55 Sell
20-day EMA: 178.43 Sell
50-day EMA: 182.97 Sell
200-day EMA: 178.57 Sell

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.67 Sell
20-day SMA: 41.77 Sell
50-day SMA: 44.36 Sell
200-day SMA: 36.53 Sell
8-day EMA: 37.84 Sell
20-day EMA: 40.59 Sell
50-day EMA: 42.71 Sell
200-day EMA: 36.35 Sell

AbbVie Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.23 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.27 per share.

AbbVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):